自身免疫性肝炎后肝硬化合并原发性免疫性血小板减少1例报告

冯颖; 周桂琴; 杨莉; 李斌; 王宪波

doi:10.3969/j.issn.1001-5256.2020.04.035

自身免疫性肝炎后肝硬化合并原发性免疫性血小板减少1例报告

DOI: 10.3969/j.issn.1001-5256.2020.04.035

首都医科大学附属北京地坛医院中西医结合一科

基金项目:

北京市自然科学基金青年基金项目(7184219)；北京市科学技术委员会资助(Z191100006619033)；

详细信息

中图分类号: R575.2;R558.2
计量
- 文章访问数: 1281
- HTML全文浏览量: 26
- PDF下载量: 235
- 被引次数: 0
出版历程
- 出版日期: 2020-04-20

Autoimmune hepatitis-associated liver cirrhosis with primary immune thrombocytopenia: A case report

First Department of Integrated Traditional Chinese and Western Medicine, Beijing Ditan Hospital

Research funding:

摘要

摘要:
<正>自身免疫性肝炎（AIH）是一种由针对肝细胞自身免疫反应所介导的肝脏实质炎症[1]。AIH常合并其他器官或系统性自身免疫性疾病如:桥本氏甲状腺炎（10%～23%）、糖尿病（7%～9%）、炎症性肠病（2%～8%）、类风湿性关节炎（2%～5%）、干燥综合征（1%～4%）、银屑病（3%）和系统性红斑狼疮（1%～2%）等[2]。而合并原发性免疫性血小板减少（primary immune thrombocytopenia,IPT）者少见,国内外均罕见报道。
- 自身免疫性肝炎 /
- 肝硬化 /
- 血小板减少
- autoimmune hepatitis /
- liver cirrhosis /
- thrombocytopenia

HTML全文

参考文献(14)

[1] SAHEBJAM F,VIERLING JM. Autoimmune hepatitis[J]. Front Med,2015,9(2):187-219.

[2] LIBERAL R,GRANT CR,MIELI-VERGANI G,et al. Autoimmune hepatitis:A comprehensive review[J]. J Autoimmun,2013,3(41):126-139.

[3] TERZIROLI BERETTA-PICCOLI B,MIELI-VERGANI G,VERGANI D. Autoimmune hepatitis:Standard treatment and systematic review of alternative treatments[J]. World J Gastroenterol,2017,23(33):6030-6048.

[4] Chinese Society of Hepatology,Chinese Medical Association;Chinese Society of Gastroenterology,Chinese Medical Association; Chinese Society of Infectious Diseases,Chinese Medical Association. Chinese consensus on the diagnosis and management of autoimmune hepatitis(2015)[J]. J Clin Hepatol,2016,32(1):9-22.(in chinese)中华医学会肝病学分会，中华医学会消化病学分会，中华医学会感染病学分会．自身免疫性肝炎诊断和治疗共识(2015)[J]．临床肝胆病杂志，2016,32(1):9-22.

[5] SAMSON M,FRASER W,LEBOWITZ D. Treatments for primary immune thrombocytopenia:A review[J]. Cureus,2019,11(10):e5849.

[6] YIN YY,SUN SJ,FANG YG,et al. Clinical efficacy of prednisone acetate in treatment of primary immune thrombocytopenia[J]. Clin J Med Offic,2019,47(12):1352-1354.(in Chinese)尹艳英，孙淑君，方永光，等．醋酸泼尼松治疗原发免疫性血小板减少症临床疗效[J]．临床军医杂志，2019,47(12):1352-1354.

[7] NEUNERT C,LIM W,CROWTHER M,et al. The American Society of Hematology 2011 evidence-based practice guideline for immune thrombocytopenia[J]. Blood,2011,117(16):4190-4207.

[8] AFDHAL N,MCHUTCHISON J,BROWN R,et al. Thrombocytopenia associated with chronic liver disease[J]. J Hepatol,2008,48(6):1000-1007.

[9] ABDELA J. Current advance in thrombopoietin receptor agonists in the management of thrombocytopenia associated with chronic liver disease:Focus on avatrombopag[J]. Clin Med Insights Blood Disord,2019,12:1179545X19875105.

[10] MARKS PW. Hematologic manifestations of liver disease[J].Semin Hematol,2013,50(3):216-221.

[11] PECK-RADOSAVLJEVIC M. Thrombocytopenia in chronic liver disease[J]. Liver Int,2017,37(6):778-793.

[12] ARNAL C,PIETTE JC,LONE J,et al. Treatment of severe immune thrombocytopenia associated with systemic lupus erythematosus:59 cases[J]. J Rheumatol,2002,29(1):75-83.

[13] MATZDORFF A,WRMANN B. Diagnosis and Therapy of Immune thrombocytopenia[J]. Dtsch Med Wochenschr,2018,143(15):1076-1081.

[14] VISCO C,RUGGERI M,LAURA EVANGELISTA M,et al. Impact of immune thrombocytopenia on the clinical course of chronic lymphocytic leukemia[J]. Blood,2008,111(3):1110-1116.

施引文献

资源附件(0)

访问统计